Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2014
Price :
$35
*
At a glance
- Drugs PRX 08066 (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors EPIX Pharmaceuticals
- 22 May 2014 New trial record